#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11224	16S	1529	1529	100.0	16S.l6.c17.ctg.2	2257	492.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	626	C	609	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11224	16S	1529	1529	100.0	16S.l6.c17.ctg.2	2257	492.1	0	HET	.	.	.	C451T	.	451	451	C	678	678	C	621	C,T	338,271	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20236	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3671	548.6	0	.	n	.	0	T695C	SNP	695	695	T	1144	1144	C	632	C	617	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20236	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3671	548.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2420	2420	C	605	C	594	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20236	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3671	548.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2494	2494	A	603	A	591	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20236	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3671	548.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3046	3046	C	630	C	612	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20236	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3671	548.6	0	HET	.	.	.	A1638G	.	1638	1638	A	2087	2087	A	604	A,G	448,148	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1450	folP	855	855	100.0	folP.l15.c4.ctg.1	1606	89.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1055	1057	AGC	139;138;137	A;G;C	133;131;131	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3794	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3616	104.5	1	SNP	p	S91F	1	.	.	271	273	TTC	660	662	TTC	133;132;132	T;T,G;C,T	130;128,1;127,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3794	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3616	104.5	1	SNP	p	D95G	1	.	.	283	285	GGC	672	674	GGC	129;129;127	G;G;C	124;126;124	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3794	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3616	104.5	1	SNP	p	G95N	0	.	.	283	285	GGC	672	674	GGC	129;129;127	G;G;C	124;126;124	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1226	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1449	84.1	1	SNP	p	G45D	0	.	.	133	135	GGC	578	580	GGC	144;141;143	G;G;C	142;138;137	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	612	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1052	58.0	0	.	n	.	0	A197.	DEL	197	197	A	592	592	A	145	A	144	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3574	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	115.8	1	SNP	p	D86N	0	.	.	256	258	GAC	620	622	GAC	140;140;144	G;A;C	136;127;138	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3574	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	115.8	1	SNP	p	R87W	0	.	.	259	261	CGT	623	625	CGT	143;144;147	C;G,A;T	139;136,1;139	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3574	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	115.8	1	SNP	p	S87R	1	.	.	259	261	CGT	623	625	CGT	143;144;147	C;G,A;T	139;136,1;139	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3574	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	115.8	1	SNP	p	R87I	0	.	.	259	261	CGT	623	625	CGT	143;144;147	C;G,A;T	139;136,1;139	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3574	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3065	115.8	1	SNP	p	S88P	0	.	.	262	264	TCC	626	628	TCC	148;148;145	T;C;C	145;144;142	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2974	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2521	116.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1513	1515	GGC	133;130;131	G;G;C	131;128;128	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1268	1270	GCC	132;133;133	G;C;C,T	130;132;128,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1271	1273	ATG	131;130;132	A;T;G	129;128;130	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1283	1285	ACC	132;133;132	A;C;CA,C	122;129;126,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1283	1285	ACC	132;133;132	A;C;CA,C	122;129;126,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1784	1786	ACC	123;121;119	A;C;C	121;120;117	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1838	1840	GCG	129;130;125	G;C;G	126;129;125	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1838	1840	GCG	129;130;125	G;C;G	126;129;125	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1961	1963	GGT	107;108;108	G,A;G;T,C	100,2;104;100,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1970	1972	AGC	104;104;104	A,G;G;C	98,2;101;96	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2852	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2416	117.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1988	1990	CCG	80;82;81	C,G;C,G;G,A,C	76,1;78,1;69,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4314	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3213	133.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1711	1713	CCG	167;164;165	C,T;C,T;G	149,1;154,1;153	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1892	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1708	108.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	491	491	C	124	C	116	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2072	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1603	128.1	0	.	p	.	0	G48E	NONSYN	142	144	GGA	477	479	GAA	157;156;161	G;A;A	154;153;159	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2072	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1603	128.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	963	965	AGA	181;179;178	A;G;A	175;172;173	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2072	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1603	128.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	984	986	GGT	188;189;189	G,A;G;T,C,G	181,1;184;175,1,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2072	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1603	128.1	1	SNP	p	G120K	1	.	.	358	360	AAG	693	695	AAG	148;149;151	A;A;G	140;145;140	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2072	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1603	128.1	1	SNP	p	A121N	1	.	.	361	363	AAC	696	698	AAC	151;150;151	A;A;C,A	144;147;141,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2072	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1603	128.1	1	SNP	p	N121D	0	.	.	361	363	AAC	696	698	AAC	151;150;151	A;A;C,A	144;147;141,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7122	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5046	140.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	850	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1221	69.1	1	SNP	p	V57M	1	.	.	169	171	ATG	603	605	ATG	154;155;157	A;T;G	154;155;156	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
